Melatonin and protection from genetic damage in blood and bone marrow: Whole-body irradiation studies in mice

Vijayalaxmi, Martin L. Meltz, Russel J Reiter, Terence S. Herman

Research output: Contribution to journalArticle

91 Citations (Scopus)

Abstract

The objective of this study was to examine the potential radioprotective properties of pharmacological doses of melatonin in whole-body irradiated mice. CD2-F1 male mice were treated with melatonin, a secretory product of the pineal gland, and then whole-body irradiated with an acute dose (150 cGy) of 137Cs gamma rays. Peripheral blood and bone marrow cells were examined for genetic damage, which was determined by comparing the incidence of micronuclei (MN) in both melatonin pre-treated and non-treated irradiated animals (and control mice). The percentages of polychromatic erythrocytes (PCEs) in unirradiated mice ranged between 3.1 ± 0.23 and 3.2 ± 0.19 in the peripheral blood and between 51.0 ± 2.03 and 52.8 ± 2.00 in the bone marrow. Whole-body irradiation resulted in a significant decrease in the percentages of PCEs in the peripheral blood and bone marrow cells. In both tissues, irradiated mice that were pre-treated with melatonin (5 or 10 mg/kg) exhibited a dose-dependent increase in the observed incidence of PCEs relative to the expected incidence. The incidence of MN in unirradiated mice ranged between 4.2 ± 0.92 and 4.6 ± 0.97 in the peripheral blood and between 5.0 ± 1.05 and 5.5 ± 1.08 in the bone marrow. Whole-body irradiation resulted in a significant increase in the incidence of MN in both tissues. In both tissues, irradiated mice that were pre-treated with melatonin exhibited a significant and dose-dependent reduction in the observed incidence of MN (relative to the expected incidence). Under the experimental conditions tested, the data indicate that melatonin has the ability to protect the genetic material of hematopoietic cells of mice from the damaging effects of acute whole-body irradiation.

Original languageEnglish (US)
Pages (from-to)221-225
Number of pages5
JournalJournal of Pineal Research
Volume27
Issue number4
DOIs
StatePublished - 1999

Fingerprint

Whole-Body Irradiation
Melatonin
Bone Marrow
Incidence
Erythrocytes
Bone Marrow Cells
Pineal Gland
Gamma Rays
Pharmacology

Keywords

  • Bone marrow
  • Gamma radiation
  • Genetic damage
  • Melatonin
  • Peripheral blood
  • Radioprotection

ASJC Scopus subject areas

  • Endocrinology

Cite this

Melatonin and protection from genetic damage in blood and bone marrow : Whole-body irradiation studies in mice. / Vijayalaxmi; Meltz, Martin L.; Reiter, Russel J; Herman, Terence S.

In: Journal of Pineal Research, Vol. 27, No. 4, 1999, p. 221-225.

Research output: Contribution to journalArticle

@article{2ab427e83f8b4eeea0c9e46f5a2b79b4,
title = "Melatonin and protection from genetic damage in blood and bone marrow: Whole-body irradiation studies in mice",
abstract = "The objective of this study was to examine the potential radioprotective properties of pharmacological doses of melatonin in whole-body irradiated mice. CD2-F1 male mice were treated with melatonin, a secretory product of the pineal gland, and then whole-body irradiated with an acute dose (150 cGy) of 137Cs gamma rays. Peripheral blood and bone marrow cells were examined for genetic damage, which was determined by comparing the incidence of micronuclei (MN) in both melatonin pre-treated and non-treated irradiated animals (and control mice). The percentages of polychromatic erythrocytes (PCEs) in unirradiated mice ranged between 3.1 ± 0.23 and 3.2 ± 0.19 in the peripheral blood and between 51.0 ± 2.03 and 52.8 ± 2.00 in the bone marrow. Whole-body irradiation resulted in a significant decrease in the percentages of PCEs in the peripheral blood and bone marrow cells. In both tissues, irradiated mice that were pre-treated with melatonin (5 or 10 mg/kg) exhibited a dose-dependent increase in the observed incidence of PCEs relative to the expected incidence. The incidence of MN in unirradiated mice ranged between 4.2 ± 0.92 and 4.6 ± 0.97 in the peripheral blood and between 5.0 ± 1.05 and 5.5 ± 1.08 in the bone marrow. Whole-body irradiation resulted in a significant increase in the incidence of MN in both tissues. In both tissues, irradiated mice that were pre-treated with melatonin exhibited a significant and dose-dependent reduction in the observed incidence of MN (relative to the expected incidence). Under the experimental conditions tested, the data indicate that melatonin has the ability to protect the genetic material of hematopoietic cells of mice from the damaging effects of acute whole-body irradiation.",
keywords = "Bone marrow, Gamma radiation, Genetic damage, Melatonin, Peripheral blood, Radioprotection",
author = "Vijayalaxmi and Meltz, {Martin L.} and Reiter, {Russel J} and Herman, {Terence S.}",
year = "1999",
doi = "10.1111/j.1600-079X.1999.tb00618.x",
language = "English (US)",
volume = "27",
pages = "221--225",
journal = "Journal of Pineal Research",
issn = "0742-3098",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Melatonin and protection from genetic damage in blood and bone marrow

T2 - Whole-body irradiation studies in mice

AU - Vijayalaxmi,

AU - Meltz, Martin L.

AU - Reiter, Russel J

AU - Herman, Terence S.

PY - 1999

Y1 - 1999

N2 - The objective of this study was to examine the potential radioprotective properties of pharmacological doses of melatonin in whole-body irradiated mice. CD2-F1 male mice were treated with melatonin, a secretory product of the pineal gland, and then whole-body irradiated with an acute dose (150 cGy) of 137Cs gamma rays. Peripheral blood and bone marrow cells were examined for genetic damage, which was determined by comparing the incidence of micronuclei (MN) in both melatonin pre-treated and non-treated irradiated animals (and control mice). The percentages of polychromatic erythrocytes (PCEs) in unirradiated mice ranged between 3.1 ± 0.23 and 3.2 ± 0.19 in the peripheral blood and between 51.0 ± 2.03 and 52.8 ± 2.00 in the bone marrow. Whole-body irradiation resulted in a significant decrease in the percentages of PCEs in the peripheral blood and bone marrow cells. In both tissues, irradiated mice that were pre-treated with melatonin (5 or 10 mg/kg) exhibited a dose-dependent increase in the observed incidence of PCEs relative to the expected incidence. The incidence of MN in unirradiated mice ranged between 4.2 ± 0.92 and 4.6 ± 0.97 in the peripheral blood and between 5.0 ± 1.05 and 5.5 ± 1.08 in the bone marrow. Whole-body irradiation resulted in a significant increase in the incidence of MN in both tissues. In both tissues, irradiated mice that were pre-treated with melatonin exhibited a significant and dose-dependent reduction in the observed incidence of MN (relative to the expected incidence). Under the experimental conditions tested, the data indicate that melatonin has the ability to protect the genetic material of hematopoietic cells of mice from the damaging effects of acute whole-body irradiation.

AB - The objective of this study was to examine the potential radioprotective properties of pharmacological doses of melatonin in whole-body irradiated mice. CD2-F1 male mice were treated with melatonin, a secretory product of the pineal gland, and then whole-body irradiated with an acute dose (150 cGy) of 137Cs gamma rays. Peripheral blood and bone marrow cells were examined for genetic damage, which was determined by comparing the incidence of micronuclei (MN) in both melatonin pre-treated and non-treated irradiated animals (and control mice). The percentages of polychromatic erythrocytes (PCEs) in unirradiated mice ranged between 3.1 ± 0.23 and 3.2 ± 0.19 in the peripheral blood and between 51.0 ± 2.03 and 52.8 ± 2.00 in the bone marrow. Whole-body irradiation resulted in a significant decrease in the percentages of PCEs in the peripheral blood and bone marrow cells. In both tissues, irradiated mice that were pre-treated with melatonin (5 or 10 mg/kg) exhibited a dose-dependent increase in the observed incidence of PCEs relative to the expected incidence. The incidence of MN in unirradiated mice ranged between 4.2 ± 0.92 and 4.6 ± 0.97 in the peripheral blood and between 5.0 ± 1.05 and 5.5 ± 1.08 in the bone marrow. Whole-body irradiation resulted in a significant increase in the incidence of MN in both tissues. In both tissues, irradiated mice that were pre-treated with melatonin exhibited a significant and dose-dependent reduction in the observed incidence of MN (relative to the expected incidence). Under the experimental conditions tested, the data indicate that melatonin has the ability to protect the genetic material of hematopoietic cells of mice from the damaging effects of acute whole-body irradiation.

KW - Bone marrow

KW - Gamma radiation

KW - Genetic damage

KW - Melatonin

KW - Peripheral blood

KW - Radioprotection

UR - http://www.scopus.com/inward/record.url?scp=0032698584&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032698584&partnerID=8YFLogxK

U2 - 10.1111/j.1600-079X.1999.tb00618.x

DO - 10.1111/j.1600-079X.1999.tb00618.x

M3 - Article

C2 - 10551769

AN - SCOPUS:0032698584

VL - 27

SP - 221

EP - 225

JO - Journal of Pineal Research

JF - Journal of Pineal Research

SN - 0742-3098

IS - 4

ER -